Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
BMC Microbiol. 2020 Nov 26;20(1):362. doi: 10.1186/s12866-020-02041-w.
Although generally known as a human commensal, Staphylococcus epidermidis is also an opportunistic pathogen that can cause nosocomial infections related to foreign body materials and immunocompromized patients. Infections are often caused by multidrug-resistant (MDR) lineages that are difficult and costly to treat, and can have a major adverse impact on patients' quality of life. Heterogeneity is a common phenomenon in both carriage and infection, but present methodology for detection of this is laborious or expensive. In this study, we present a culture-independent method, labelled Epidome, based on an amplicon sequencing-approach to deliver information beyond species level on primary samples and to elucidate clonality, population structure and temporal stability or niche selection of S. epidermidis communities.
Based on an assessment of > 800 genes from the S. epidermidis core genome, we identified genes with variable regions, which in combination facilitated the differentiation of phylogenetic clusters observed in silico, and allowed classification down to lineage level. A duplex PCR, combined with an amplicon sequencing protocol, and a downstream analysis pipeline were designed to provide subspecies information from primary samples. Additionally, a probe-based qPCR was designed to provide valuable absolute abundance quantification of S. epidermidis. The approach was validated on isolates representing skin commensals and on genomic mock communities with a sensitivity of < 10 copies/μL. The method was furthermore applied to a sample set of primary skin and nasal samples, revealing a high degree of heterogeneity in the S. epidermidis populations. Additionally, the qPCR showed a high degree of variation in absolute abundance of S. epidermidis.
The Epidome method is designed for use on primary samples to obtain important information on S. epidermidis abundance and diversity beyond species-level to answer questions regarding the emergence and dissemination of nosocomial lineages, investigating clonality of S. epidermidis communities, population dynamics, and niche selection. Our targeted-sequencing method allows rapid differentiation and identification of clinically important nosocomial lineages in low-biomass samples such as skin samples.
虽然表皮葡萄球菌通常被认为是一种人类共生菌,但它也是一种机会性病原体,可导致与异物材料和免疫功能低下患者相关的医院感染。感染通常由多药耐药(MDR)谱系引起,这些谱系难以治疗且费用高昂,并且会对患者的生活质量产生重大不利影响。异质性在携带和感染中都很常见,但目前用于检测这种异质性的方法既费力又昂贵。在这项研究中,我们提出了一种基于扩增子测序的非培养方法——Epidome,该方法不仅能够提供物种水平以上的原发性样本信息,还能够阐明表皮葡萄球菌群落的克隆性、种群结构和时间稳定性或生态位选择。
基于对表皮葡萄球菌核心基因组中 800 多个基因的评估,我们鉴定出了具有可变区的基因,这些基因组合在一起促进了我们在计算机上观察到的进化群的分化,并允许对谱系水平以下的分类进行分类。设计了一种双重 PCR,结合扩增子测序方案和下游分析管道,从原发性样本中提供亚种信息。此外,还设计了一种基于探针的 qPCR,可对表皮葡萄球菌进行有价值的绝对丰度定量。该方法在代表皮肤共生菌的分离株和基因组模拟群落上进行了验证,其灵敏度低于 10 拷贝/μL。该方法进一步应用于一组原发性皮肤和鼻腔样本,揭示了表皮葡萄球菌种群的高度异质性。此外,qPCR 显示表皮葡萄球菌的绝对丰度存在很大差异。
Epidome 方法旨在用于原发性样本,以获得有关表皮葡萄球菌丰度和多样性的重要信息,超越物种水平,以回答有关医院感染谱系出现和传播的问题,研究表皮葡萄球菌群落的克隆性、种群动态和生态位选择。我们的靶向测序方法允许在低生物量样本(如皮肤样本)中快速区分和鉴定具有临床重要性的医院感染谱系。